The US is dangerously close to falling behind China in biotech, and the government should spend a minimum of $15 billion over ...

At the same time that Donald Trump was saying that a "major tariff" on pharmaceuticals is coming to force more manufacturers ...

In this webinar – ‘Enabling Digitally Enhanced Care for Rare Diseases in Europe: Integrating AI and Connected Care ...

UK medtech company Brainomix has been granted FDA approval for a new feature for its artificial intelligence-powered stroke ...

AstraZeneca and Daiichi Sankyo have claimed approval from the European Commission for their TROP2-directed antibody-drug ...

European Commission President Ursula von der Leyen is scheduled to meet with EU pharma leaders today about how to respond to ...

AbbVie has picked up another indication for its JAK inhibitor Rinvoq in the EU, becoming the first approved oral therapy for ...

GSK's clinical-stage pipeline is currently focused on oncology, respiratory, immunology and inflammation, and infectious ...

The UK government has said it will invest up to £600 million ($764 million) in the creation of a centralised health data ...

The latest rejection looks set to mark the end of J&J's drive to resolve the litigation through the bankruptcy courts, as the ...

The EMA has called a temporary halt to a phase 2 trial of Sarepta's Roche-partnered Duchenne muscular dystrophy (DMD) gene ...

In some ways, pharma connecting directly with patients isn’t novel at all: pharma companies in the United States have been ...